Pepvise
Compound profile· Evidence

Peptides for muscle growth, honestly graded

By The PepVise Editorial Team · Reviewed June 4, 2026 · 11 min read

Growth-hormone secretagogues, IGF-1 peptides and collagen all get sold for muscle. What the human trials actually show, why GH peptides disappoint lifters, and the legal options that beat all of them.

We describe what has been measured — by whom, at what scale, with what effect size, and with what caveats. Hedging, here, is honesty.
The PepVise Editorial Teamfrom the house style guide
Methodology

How we read the literature

Evidence tier
We grade the literature on four tiers, High (replicated RCTs or meta-analyses), Moderate (multiple trials with mixed findings), Low (a single pilot or case series), and Anecdotal (preclinical only, no human data). The tier appears on every compound profile beside the claim it supports.
Trial stage
Where a compound sits in the human development pipeline is recorded as Preclinical, Phase 1, Phase 2, or Phase 3+. We pull the current stage from ClinicalTrials.gov and the EU Clinical Trials Register on access date and re-verify quarterly.
Regulatory status
We state the FDA posture plainly, approved for indication X, or labeled for research use only, or removed from the 503A list, or investigational under a specific IND. Regulatory status changes; every post carries a review date.
Where we're uncertain
Every compound profile closes with a named uncertainty section, the question we can't answer from the current literature, the trial we'd want to see, the effect size we'd treat as a real signal. Uncertainty is not a failure mode here; it's load-bearing.
Frequently asked

The questions readers actually bring us.

Do peptides build muscle?
No peptide in the research channel has strong human trial evidence for building muscle in healthy adults. The GH secretagogues (ipamorelin, CJC-1295) raise growth hormone but studies show that adds mostly fluid and connective tissue, not strength. The only peptide with a positive muscle trial is collagen, and only in older adults paired with resistance training.
Are CJC-1295 and ipamorelin good for muscle growth?
They reliably raise GH pulses, but no controlled trial shows muscle or strength gains in healthy trainees from that, and GH research generally finds increased lean-mass readings without improved strength. They are popular in gym forums on mechanism logic, not outcome data. Both have full graded reviews on PepVise.
What is the best peptide for muscle recovery?
Recovery is a more defensible claim than hypertrophy for some peptides, but still thin. BPC-157 has preclinical tendon data and collagen-plus-loading has human tendon-synthesis evidence; the GH peptides' recovery claims are mostly anecdotal. None has the evidence base of simply sleeping and eating enough protein.
Is collagen good for building muscle?
It has the only positive muscle trial among these peptides (15 g daily plus resistance training improved fat-free mass in elderly men), but it is a low-quality, leucine-poor protein that underperforms whey for muscle protein synthesis. For a healthy lifter eating enough protein, whey or a mixed diet is the better muscle choice.
What works better than peptides for muscle?
Resistance training, adequate protein (1.6 to 2.2 g/kg/day), creatine monohydrate, and sleep, in that order. All four are better evidenced, cheaper, safer and legal compared with any research-channel peptide marketed for muscle. PepVise covers creatine in its supplement context.
What would change our reading

A Phase 2 randomized trial with blinded outcome assessment would change the reading. A new independent replication outside the currently dominant research group would change the reading. A regulatory action — approval, restriction, or a class warning — would change the reading. When any of those lands, we update this profile within a week and mark what changed.

The masthead

About The Pepvise Editorial Team

The Pepvise Editorial Team is a small group of researchers and science writers reading the peer-reviewed peptide literature and translating it into calm, cited analysis. We do not sell peptides, recommend peptides, or tell readers what to administer. We describe what has been measured, by whom, at what scale, with what effect size.

Compound reviews are signed off by Dr. Priya Narang, MD, MPH (endocrinologist) and Dr. Marcus Haley, PharmD, BCPS (board-certified clinical pharmacist). Both hold verifiable state-board licenses and have signed editorial-independence letters with us. See the full editorial board →

Further reading

Adjacent in the literature.

Get the 2026 Peptide Evidence Ledger.

A 12-page PDF summary of where 10 major compounds sit, Preclinical / Human pilot / Phase trial / FDA status. Updated quarterly. Free.

By subscribing, you agree to our Privacy Policy. One calm, cited email a week. Unsubscribe anytime.